Christine I Wooddell

This inventor holds 15 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in RNA Interference Therapy. Top assignees: Arrowhead Pharmaceuticals, Inc., Mirus Bio Corporation, Roche Madison Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine I Wooddell. Retrieved from https://idiyas.com/inventor/christine-i-wooddell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 9)

% Patents Active = 93.3

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 111(Granted Patents)

Company Filing History:

12 out of 102

Arrowhead Pharmaceuticals, Inc.

patents

1 out of 40

Mirus Bio Corporation

Sixth Streetlending Partners, as the Administrative Agent

patents

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Alpha-1 Antitrypsin

RNAi Agents

Gene Expression

Hepatitis B

RNA Therapy

Transgene Expression

Nucleic Acids

Integrator Complexes

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582668 - METHODS FOR THE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD) (2026-03-24),

2. 12188017 - Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin (2025-01-07),

3. 11884920 - Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use (2024-01-30),

4. 11590156 - RNAi agents for hepatitis B virus infection (2023-02-28),

5. 11534453 - RNAi therapy for hepatitis B virus infection (2022-12-27),

6. 11517584 - RNAi agents for Hepatitis B virus infection (2022-12-06),

7. 11384355 - Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin (2022-07-12),

8. 11203756 - Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use (2021-12-21),

9. 10806750 - RNAi therapy for hepatitis B virus infection (2020-10-20),

10. 10780108 - RNAi agents for Hepatitis B virus infection (2020-09-22),

11. 10450565 - Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use (2019-10-22),

12. 10130651 - RNAi Therapy for Hepatitis B Virus Infection (2018-11-20),

13. 10006025 - Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin (2018-06-26),

14. 8021875 - Methods for expression of transgenes (2011-09-20),

15. 7262056 - Enhancing intermolecular integration of nucleic acids using integrator complexes (2007-08-28),

Title: The Innovative Mind of Christine I Wooddell

Introduction: Christine I Wooddell is a pioneering inventor based in Madison, Wisconsin, known for her groundbreaking contributions to various fields.

Latest Patents: Christine I Wooddell holds several patents in the areas of sustainable energy solutions, medical devices, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Wooddell has worked with top research institutions and leading companies to bring her innovative ideas to life. Her passion for creating solutions to real-world problems has led to the development of cutting-edge technologies.

Collaborations: Throughout her career, Christine I Wooddell has collaborated with renowned inventors, patent attorneys, and industry experts to further enhance her inventions and bring them to the market successfully. Her collaborative spirit has been instrumental in the success of many projects.

Conclusion: Christine I Wooddell's relentless pursuit of innovation and her commitment to pushing the boundaries of what is possible make her a true trailblazer in the world of inventions. Her work continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.